Johnson & Johnson to test COVID-19 vaccine in children ages 12 and up – Business Insider – Business Insider

Johnson & Johnson plans to start testing its experimental COVID-19 vaccine in youths aged 12 to 18 as soon as possible, a company executive said at a meeting held by the US Centers for Disease Control and Prevention (CDC) on Friday.

"We plan to go into children as soon as we possibly can, but very carefully in terms of safety," J&J's Dr. Jerry Sadoff told a virtual meeting of the CDC's Advisory Committee on Immunization Practices.

Depending on safety and other factors, the company plans to test in even younger children afterwards, Sadoff, a vaccine research scientist at J&J's Janssen unit, said.

Read more: 5 takeaways from the first FDA coronavirus vaccine meeting

A clinical trial volunteer participates in Johnson & Johnson's study to test a coronavirus vaccine. Janssen

J&J started testing the vaccine in adults in a 60,000-volunteer phase-three study in late September. It had to pause the trial earlier this month because of a serious medical event in one participant. The study resumed last week.

Rival drugmaker Pfizer Inc. has already begun testing the COVID-19 vaccine it is developing with Germany's BioNTech in children as young as 12.

Read more: Pfizer and Moderna are neck-and-neck in the race to deliver the first effective coronavirus vaccine. Here's everything we know about the timeline and when you might be able to get a shot.

Reporting by Michael Erman; Editing by Chizu Nomiyama and Bill Berkrot.

Follow this link:

Johnson & Johnson to test COVID-19 vaccine in children ages 12 and up - Business Insider - Business Insider